Century Therapeutics, Inc.
Public company- Headquarters
- PHILADELPHIA, Pennsylvania
- Industry
- Biotechnology
- Ticker
- IPSC
- CIK
- 0001850119
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class I directorJoseph Truitt | Sep 9, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
- AMGEN INC
director appointed: David W. Gibbs
- Executive appointment
Class I director appointed: Joseph Truitt
Joseph Truitt was named Class I director of Century Therapeutics, Inc., effective September 9, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 9, 2026Role: Class I director
- WARN notice
WARN notice: Philadelphia, PA
Century Therapeutics, LLC filed a WARN notice with the Pennsylvania WARN list covering 72 workers at 25 North 38th Street, Philadelphia, PA 19104. The layoffs take effect on Jul 11, 2025.
Source: Pennsylvania WARN list, filed Jul 11, 2025Site: Philadelphia, PA
Workers affected: 72
Last verified Nov 8, 2026